Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

Mark A. Ware, Tongtong Wang, Stan Shapiro, Ann Robinson, Thierry Ducruet, Thao Huynh, Ann Gamsa, Gary J. Bennett and Jean-Paul Collet
CMAJ October 05, 2010 182 (14) E694-E701; DOI: https://doi.org/10.1503/cmaj.091414
Mark A. Ware
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tongtong Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stan Shapiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Robinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Ducruet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thao Huynh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Gamsa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary J. Bennett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Paul Collet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 1: Flow of patients through the randomized controlled trial.

  • Figure2
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 2: Levels of tetrahydrocannabinol (THC) in plasma after inhalation of a single dose. Data are presented as means and standard deviations.

Tables

  • Figures
  • Table 1: Demographic and baseline characteristics of participants

    Table1
  • Table 2: Pairwise comparisons of the effects of four potencies of smoked cannabis on average daily pain

    Table2
  • Table 3: Effects of smoked cannabis and secondary outcomes, by potency of tetrahydrocannabinol (THC) received

    Table3
  • Table 4: Adverse events reported during the study, by potency of tetrahydrocannabinol (THC) (part 1 of 2)

    Table4
  • Table 4: Adverse events reported during the study, by potency of tetrahydrocannabinol (THC) (part 2 of 2)

    Table5
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 182 (14)
CMAJ
Vol. 182, Issue 14
5 Oct 2010
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware, Tongtong Wang, Stan Shapiro, Ann Robinson, Thierry Ducruet, Thao Huynh, Ann Gamsa, Gary J. Bennett, Jean-Paul Collet
CMAJ Oct 2010, 182 (14) E694-E701; DOI: 10.1503/cmaj.091414

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware, Tongtong Wang, Stan Shapiro, Ann Robinson, Thierry Ducruet, Thao Huynh, Ann Gamsa, Gary J. Bennett, Jean-Paul Collet
CMAJ Oct 2010, 182 (14) E694-E701; DOI: 10.1503/cmaj.091414
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • More evidence cannabis can help in neuropathic pain
  • PubMed
  • Google Scholar

Cited By...

  • Working With Clients Who Opt to Use Marijuana as an Alternative Treatment for Chronic Health Conditions
  • Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury
  • Cannabis for peripheral neuropathy: The good, the bad, and the unknown
  • Medical marijuana research
  • Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials
  • Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach
  • Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
  • Prescrire du cannabis fume pour la douleur chronique non cancereuse: Recommandations preliminaires
  • Impact of Efficacy at the {mu}-Opioid Receptor on Antinociceptive Effects of Combinations of {mu}-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
  • New medical marijuana regulations: the coming storm
  • Marijuana is not a prescription medicine
  • Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides
  • Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
  • Cannabis and Its Derivatives: Review of Medical Use
  • Google Scholar

More in this TOC Section

  • The experiences of family members of deceased organ donors and suggestions to improve the donation process: a qualitative study
  • Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario
  • Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
Show more Research

Similar Articles

Collections

  • Topics
    • Cannabis
    • Pain

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire